Emergency Department Screening Detects Prediabetes, Type 2 Diabetes
Only 25% of patients who were identified self-reported having been diagnosed with prediabetes or type 2 diabetes.
Type 2 Diabetes Information Center
Top January 2023 FDA Approvals
January FDA approvals include treatments for mood disorders, pertussis in infants, Alzheimer disease, and type 2 diabetes.
Total Nitrites Consumption Tied to Higher Type 2 Diabetes Risk
Total nitrates consumption increases a person’s risk of developing type 2 diabetes.
Rybelsus Now First-Line Option for Type 2 Diabetes Following Label Update
Rybelsus is a glucagon-like peptide receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Layered Approach Recommended for Patients With Diabetes, CKD
Layered approach involves initially combining lifestyle interventions, self-management, and first-line pharmacotherapy.
Risk for Type 2 Diabetes Reduced With Higher Daily Step Count
Hazard of incident diabetes reduced by 44% in adjusted models comparing average daily step count of 10,700 to 6000.
Not All Children With Type 2 Diabetes Have Obesity
Meta-analysis results show the prevalence of obesity among children with type 2 diabetes.
2023 Standards of Care in Diabetes Released
ADA’s Dr Gabbay discusses the top changes to the Standards of Care in Diabetes—2023
New Guideline on Diabetes-Related Hypoglycemia Management Released
Endocrine Society Clinical Practice Guideline examines better ways to manage hypoglycemia in people with diabetes.
Insulin Rationing Reported by 16.5 Percent of Insulin Users
Variation seen among subgroups, with rationing in 11.2% of those aged 65 years and older and 20.4% of younger persons.
Can SGLT2 and GLP1 Agents Be Cost-Effective First-Line Treatments for Diabetes?
Researchers evaluate the lifetime cost-effectiveness of using SGLT2 inhibitors or GLP1 receptor agonists as first-line treatments for type 2 diabetes.
Effects of Weight Loss Methods Examined by Baseline Body Weight
Unlike people with obesity, lean individuals may not experience health benefits with intentional weight loss.
USPSTF: Evidence Lacking for Screening Children for Prediabetes, T2D
Evidence insufficient for assessing benefits and harms of screening for children and adolescents.
Effect of Keto and Mediterranean Diets on Glucose Control Compared
Limiting added sugar and refined grains helpful, but no added overall health benefit seen for cutting out legumes, fruits, and whole grains.
FDA Clears PENS Device for Pain Related to Diabetic Peripheral Neuropathy
First Relief is a wearable PENS device that is placed behind the ear.
California Will Produce Its Own Insulin to Bring Down Prices
As part of California’s new budget, $50 million will go directly to the development of low-cost insulin products to increase access for patients with diabetes.
Obesity in Adolescence Linked to Type 1 Diabetes in Adulthood
Adolescent obesity is correlated with both adult-onset type 1 diabetes and type 2 diabetes.
Metformin, Lifestyle Changes Cut Risk for T2DM, But Not CVD
No reduction seen in first occurrence of nonfatal MI, stroke, or CV death with either metformin or lifestyle intervention vs placebo.
Risk for Hospitalization for Heart Failure Down With SGLT-2i Treatment for T2D
Researchers conducted a population-based cohort study involving patients with T2D aged 18 years and older initiating treatment with SGLT-2i or metformin.
Metformin and Improved Clinical Outcomes in Comorbid Heart Failure and Diabetes
Researchers sought to evaluate the relationship between initiation of metformin and sulfonylurea therapy and clinical outcomes in patients with HF and diabetes.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Type 2 Diabetes Information Center
Loading... 
Loading...